Glimepiride 4 mg

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, IInstituto Gallego de Medicina Vascular

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 1

Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)

CompletedNCT01614769

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2012-07-18End: 2013-01-23Updated: 2018-08-16

Phase 4

Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.

IInstituto Gallego de Medicina VascularDiabetes Mellitus, Type 2

Start: 2016-12-13End: 2019-08-31Target: 159Updated: 2017-03-29